D.E. Shaw & Co’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-17,700
Closed -$1.07M 4043
2020
Q2
$1.07M Hold
17,700
﹤0.01% 2877
2020
Q1
$877K Buy
17,700
+4,700
+36% +$357K ﹤0.01% 2841
2019
Q4
$1.06M Buy
13,000
+4,600
+55% +$377K ﹤0.01% 2943
2019
Q3
$692K Hold
8,400
﹤0.01% 3047
2019
Q2
$655K Sell
8,400
-800
-9% -$62.2K ﹤0.01% 2932
2019
Q1
$723K Buy
9,200
+5,400
+142% +$429K ﹤0.01% 2802
2018
Q4
$287K Sell
3,800
-4,000
-51% -$301K ﹤0.01% 3373
2018
Q3
$590K Hold
7,800
﹤0.01% 3015
2018
Q2
$575K Hold
7,800
﹤0.01% 3035
2018
Q1
$525K Buy
+7,800
New +$533K ﹤0.01% 2860

Other funds holding NHI

D.E. Shaw & Co's NHI Position: Q1 2026 in Review

D.E. Shaw & Co reduced its National Health Investors (NHI) stake by 57% in Q1 2026, selling an estimated $1.17M and leaving 10,483 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #3551.

D.E. Shaw & Co first reported a position in NHI in Q4 2013 and has held it in 26 quarters since. The position peaked at $7.5M in Q1 2016. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.

  • D.E. Shaw & Co held 10,483 shares of National Health Investors worth $848K as of Q1 2026.
  • D.E. Shaw & Co sold 14,047 National Health Investors shares in Q1 2026, an estimated $1.17M.
  • National Health Investors made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3551 holding.
  • D.E. Shaw & Co first reported a position in National Health Investors in Q4 2013 and has held it in 26 quarters since.
  • D.E. Shaw & Co's National Health Investors position peaked at $7.5M in Q1 2016.
  • 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.